Cheongidan: the premium line with multifunctional properties—anti-aging, hydrating and whitening. Ingredients include velvet deer antler extract, jade extract, gold and ginseng extracts along with more than 30 other herbal ingredients.
The History of Whoo is recommended for those with dull, dry skin regardless of age, and basically anybody who vouches for Korean skincare products with natural, herbal ingredients along with a penchant for strikingly ornamental packaging design. You gotta admit that these jars of anti-aging elixirs combine elegance and Asian style elements beautifully.
Order of Cheongidan Hwa Line
1.The history of Whoo Cheongidan Hwa Hyun Balance
2.The history of Whoo Cheongidan Hwa Hyun Essence
2.The history of Whoo Cheongidan Hwa Hyun Essence
3.The history of Whoo Cheongidan Hwa Hyun Lotion
4.The history of Whoo Cheongidan Hwa Hyun Eyecream
5.The history of Whoo Cheongidan Hwa Hyun Cream
Complete Cheongidan Hwa Hyun line (some discontinued product)
1.The history of Whoo Cheongidan Hwa Hyun Balancer
2.The history of Whoo Cheongidan Hwa Hyun Gold Program (discontinued)
3.The history of Whoo Cheongidan SanYangSam Ampoule oil
4.The history of Whoo Cheongidan Hwa Hyun Essence
5.The history of Whoo Cheongidan Hwa Hyun Lotion
6.The history of Whoo Cheongidan Hwa Hyun Eye Cream
7.The history of Whoo Cheongidan Hwa Hyun Cream
特点功效
天气丹华泫系列是Whoo后最为高端的基础护理产品,使用了稀有珍贵的成分,从中医学角度来讲,所护理的不光是皮肤表面,更是皮肤的深层细胞,调养肌肤更加健康剔透,保持永久的美丽。
天气丹华泫系列是按照慈禧太后到了80岁仍然保持宛若17岁皮肤的宫廷秘方的逆时空活肤化妆肌肤保养品。为Whoo后系列产品中基础护肤最高端的一款,有很强的抗氧化效果,能从根本上解决肌肤的油水平衡问题,能使肌肤保持一整天的油水平衡。并且有生机成分,可以促进肌肤细胞的迅速代谢和再生。
天气丹华泫系列中的三大主成分山参玉珠、鹿茸粉骨、黄金紫杉,配以26种慈禧宫廷养颜秘方,以及Whoo后独有专利的基础配方共36种中药研制而成。通过蒸馏法,让其中药成分更加温和。提取最为精髓的精华。
* 山参玉珠:也叫野山参或山参须点,可以抗衰老、增加血液循环,具有令肌肤莹润丰满而富有光泽,提高皮肤的抵抗力,防止皮肤细胞癌变,促进新陈代谢的作用。
* 鹿茸粉骨:含有细胞生长因子和表皮生长因子,有益于修复机体和护养皮肤。鹿茸含有25种氨基酸、多种维他命及微量元素,有提高免疫力、促进细胞造血功能、促进伤口愈合等多种养护调理功效。
* 黄金紫杉:因资源稀少价格堪比黄金而得名,又名红豆杉,赤柏松,是世界上公认的濒临灭绝的天然珍稀抗癌植物,是第四纪冰川遗留下来的古老树种,在地球上已有250万年的历史,其提炼出的紫杉醇对防治肿瘤、癌症、白血病、糖尿病等疑难杂症有特殊的功效。
26种慈禧养颜秘方:慈禧为美容养颜甄选极尽珍贵的中药材配为供其专享的宫廷养颜秘方,据史料记载这让慈禧即便到了晚年70多岁皮肤一如少女般白嫩,肤如凝脂。
No comments:
Post a Comment